Keywords: astrazeneca, cholesterol-lowerer, crestor, gets, fda, panel, backing
AstraZeneca's cholesterol-lowerer Crestor gets FDA panel backing
Article | 14 July 2003
The US Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory Committee voted unanimously July 9 to back approval of AstraZeneca's ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
